METHYLPREDNISOLONE CONCENTRATIONS IN THE VITREOUS AND THE SERUM AFTER PULSE THERAPY
Authors:
- F. F. Behar-CohenFBF. F. Behar-Cohen
- S. GauthierSGS. Gauthier
- A. ElaouniAEA. Elaouni
- P. ChaponPCP. Chapon
- J. M. ParelJPJ. M. Parel
- G. RenardGRG. Renard
- D. ChauvaudDCD. Chauvaud
- 1 February 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Retina
- Vol. 21 (1) , 48-53
Abstract
Intravenous (IV) pulse of corticosteroids has been used to treat severe eye inflammation from different origins. Whether such large doses result in vitreous levels that differ either in magnitude or duration from more conventional corticotherapy remain unsolved issues. The authors therefore determined levels of methylprednisolone hemisuccinate and methylprednisolone in the vitreous and serum of patients at different times after a single IV perfusion of methylprednisolone hemisuccinate. Fifty patients scheduled for a first vitrectomy received an IV injection of 500 mg hemisuccinate methylprednisolone at different times before surgery (from 15–24 hours). Patients were divided into two groups: those with (n = 21) and without (n = 29) retinal detachment (RD). Pure vitreous samples were analyzed by high-pressure liquid chromatography. Both the ester and the nonester methylprednisolone forms were sampled in the vitreous, showing a slower rate of hydrolysis compared to the serum. On average, the highest concentration of total methylprednisolone in the vitreous was found at 2.5 hours and rapidly decreased for the group of patients with RD. In the group of patients without RD, the highest concentration was reached at 6 hours and then slowly decreased. The antiinflammatory potency in the nondetached retina eyes was approximately 500 times more than in the physiologic vitreous, but despite the route of administration (IV or oral), only 1/10 of the corticosteroid serum concentration was measured in the vitreous. High concentration of methylprednisolone is achieved by IV pulse therapy without changing the kinetic of entry in the vitreous of nondetached retina eyes when compared to conventional oral corticotherapy. Hydrolysis occurs in the vitreous resulting in high rate of active form. Pulse therapy could be considered in cases of severe ocular inflammation involving the posterior segment of the eye.Keywords
This publication has 16 references indexed in Scilit:
- Dexamethasone Concentration in Vitreous and Serum After Oral AdministrationAmerican Journal of Ophthalmology, 1998
- Corticosteroids in Corneal Graft Rejection: Double Versus Single Pulse TherapyCornea, 1994
- The use of a single pulse of intravenous methylprednisolone in the treatment of corneal graft rejection. A preliminary reportEye, 1991
- Methylprednisolone pharmacokinetics after intravenous and oral administration.British Journal of Clinical Pharmacology, 1989
- Pharmacokinetics and pharmacodynamics of esmolol administered as an intravenous bolusClinical Pharmacology & Therapeutics, 1987
- High-performance liquid chromatographic determination of methylprednisolone and methylprednisolone 21-[8-[methyl-(2-sulfoethyl) amino]-8-oxoctanoate] sodium salt in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Intravenous Pulse Methylprednisolone Therapy in Severe Inflammatory Eye DiseaseArchives of Ophthalmology (1950), 1986
- Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adultsEuropean Journal of Clinical Pharmacology, 1986
- Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1982
- REVERSAL OF ACUTE CLINICAL AND EXPERIMENTAL ORGAN REJECTION USING LARGE DOSES OF INTRAVENOUS PREDNISOLONEThe Lancet, 1971